Bing Wang

Dr Bing Hui Wang trained in Chemistry (BSc and MSc) and gained a PhD in the Department of Biochemistry, La Trobe University. His post-doctoral research has been in the area of cellular signaling in cardiac vascular diseases. He was a senior research officer at the Baker Heart Research Institute for four years and involved in studies on the roles of adrenergic receptors in cardiac function and discovered inositol polyphosphate 1-phosphatase as a novel anti-hypertrophic factor.

He then changed his career to commercial research in biotechnology industry. During his research as the Senior Scientist and Head of the Molecular Biology Department, at Cytopia Pty Ltd he made substantial contributions to many of the patents and other intellectual properties.

In October, 2005, Dr Wang re-joined academic research by taking up a Senior Research Fellow position with Prof Henry Krum, Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University. Under the mentorship of Prof Krum, Dr Wang has made significant progress and contribution to academic research in the areas of cardiovascular pharmacology, drug discovery and development, and cardiorenal syndrome research. Dr Wang has expertise in molecular and cellular biology, biomarkers and protein biochemistry, drug design and development, natural products chemistry and pharmacology, especially in signaling mechanisms of inflammatory cytokines and mediators/biomarkers in cardiovascular and renal diseases including heart failure and chronic kidney diseases.